Gene-editing alternative corrects Duchenne muscular dystrophy

(UT Southwestern Medical Center) Using the new gene-editing enzyme CRISPR-Cpf1, researchers at UT Southwestern Medical Center have successfully corrected Duchenne muscular dystrophy in human cells and mice in the lab.